5AG-15141-10769
3 vaccinations
3 coded responses
16 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 335 / FL
- Registered
- 2022-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2022-01-08
Registered in v-safe
-
2022-01-08
Dose 3 — Pfizer-BioNTech
- 2022-01-08
-
2022-01-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-10
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-01-11
-
2022-01-12
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — days 1–6 daily, dose 3MedDRA: Throat irritation — Feeling: GoodFree text: Throat irritationMedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
- 2022-01-15
- 2022-01-22
- 2022-01-30
- 2022-02-05
- 2022-02-13
- 2022-02-19
- 2022-04-09
-
2022-07-11
Survey response — 6 months, dose 3MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Typical cold symptoms, congestion and cough.MedDRA releases: 2024-11 · check-in free text available
- 2023-01-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | No |
| 2 | 2021-04-27 | Pfizer-BioNTech | No |
| 3 | 2022-01-08 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Systemic reaction (other): Throat irritation
Release 12 — 6 months, dose 3
Symptoms: Typical cold symptoms, congestion and cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release